Integra Lifesciences Holdings (IART) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.89% |
| Dec 31, 2025 | -0.07% |
| Sep 30, 2025 | 1.09% |
| Jun 30, 2025 | 1.58% |
| Mar 31, 2025 | 3.29% |
| Dec 31, 2024 | 4.10% |
| Sep 30, 2024 | 3.97% |
| Jun 30, 2024 | 4.37% |
| Mar 31, 2024 | 4.93% |
| Dec 31, 2023 | 4.00% |
| Sep 30, 2023 | 3.30% |
| Jun 30, 2023 | 3.47% |
| Mar 31, 2023 | 2.88% |
| Dec 31, 2022 | 3.91% |
| Sep 30, 2022 | 9.50% |
| Jun 30, 2022 | 12.30% |
| Mar 31, 2022 | 12.38% |
| Dec 31, 2021 | 15.91% |
| Sep 30, 2021 | 15.61% |
| Jun 30, 2021 | 15.40% |
| Mar 31, 2021 | 15.37% |
| Dec 31, 2020 | 15.30% |
| Sep 30, 2020 | 13.57% |
| Jun 30, 2020 | 15.67% |
| Mar 31, 2020 | 17.33% |
| Dec 31, 2019 | 15.78% |
| Sep 30, 2019 | 16.71% |
| Jun 30, 2019 | 16.05% |
| Mar 31, 2019 | 15.55% |
| Dec 31, 2018 | 21.12% |
| Sep 30, 2018 | 21.84% |
| Jun 30, 2018 | 21.82% |
| Mar 31, 2018 | 22.94% |
| Dec 31, 2017 | 22.51% |
| Sep 30, 2017 | 15.32% |
| Jun 30, 2017 | 12.58% |
| Mar 31, 2017 | 12.08% |
| Dec 31, 2016 | 9.58% |
| Sep 30, 2016 | 9.24% |
| Jun 30, 2016 | 9.47% |
| Mar 31, 2016 | 12.69% |
| Dec 31, 2015 | 11.73% |
| Sep 30, 2015 | 13.76% |
| Jun 30, 2015 | 11.70% |
| Dec 31, 2014 | 11.05% |